Study of treatment outcomes in sinonasal cancer patients
Part of Cancer, Ear, nose & throat clinical trials.
This study follows people who have sinonasal cancer and are being treated at Mayo Clinic. It looks at how patients do over time, which may help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your age must be from 1 month to 99 years old (not including 1 month).
- You have been diagnosed with sinonasal cancer.
- You are currently receiving treatment at Mayo Clinic.
- You are willing to sign the informed consent form.
- This is for cancer patients, not healthy individuals.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy and a targeted drug called tazemetostat for a rare type of nasal cancer that has not spread. The goal is to see if this combination can shrink the tumor and improve outcomes.
This study looks at whether surgery followed by radiation helps people with a specific type of sinus cancer called adenoid cystic carcinoma that has grown into nearby tissues. It aims to see how well this treatment works and how safe it is.
This study compares surgery alone versus surgery followed by radiation therapy for a rare type of nasal or sinus cancer. It aims to see if adding radiation after surgery helps prevent the cancer from coming back.
This study collects information about how patients do after radiation treatment and stores some biological samples for future research. It includes people treated at Mayo Clinic Rochester for a cancer-focused (curative) course of radiation.
This study looks at how symptoms and everyday functioning change for people with cancers of the nose/sinuses, the throat behind the nose (nasopharynx), or nearby skull-base areas. It may help doctors understand what survivors experience and improve long-term care.
This study looks at how doctors manage tumors that start in the nose/sinuses and spread to the skull base. It may help improve planning of care for people with this specific type and location of tumor.
Hear when a new Sinonasal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.